Table 1.
Patient, lesion, procedure characteristics, and outcome
| Parameters | Number of patients, n (%) |
|---|---|
| Total number of patients | |
| Men | 57 (96.61) |
| Women | 2 (3.39) |
| Symptoms | |
| Symptoms of lower limb ischemia | 59 (100) |
| Gangrene | 22 (37.29) |
| Cardiovascular risk factors and comorbidities | |
| Arterial hypertension | 24 (40.68) |
| Diabetes mellitus | 41 (69.49) |
| Smoking | 34 (57.63) |
| Hyperlipidemia | 11 (18.64) |
| Coronary heart disease or previous myocardial infarction | 4 (6.78) |
| Previous arterial bypass surgery | 0 |
| Previous ischemic stroke or transient ischemic attack | 0 |
| Other peripheral arterial disease | 5 (8.47) |
| Lesion severity (suprainguinal) (%) | |
| 100 | 11 (61.11) |
| 90-100 | 7 (38.89) |
| Lesion severity (SFA) 100% | 59 (100) |
| Lesion severity (infrainguinal) 100% | 4 (100) |
| Lesion length (suprainguinal) (mm) | |
| <30 | 2 (11.11) |
| 30-60 | 10 (55.56) |
| >60 | 6 (33.33) |
| Lesion length (SFA) (mm) | |
| <100 | 13 (22.03) |
| 100-200 | 20 (33.90) |
| >200 | 26 (44.07) |
| Lesion length (infrainguinal) (mm) | |
| <100 | 0 |
| >100 | 4 (100) |
| Lesion duration | |
| <1 month | 6 (10.17) |
| 1-3 months | 19 (32.20) |
| 3-12 months | 31 (52.54) |
| >1 year | 3 (5.08) |
| Atherosclerotic | 59 (100) |
| Stent used (suprainguinal) | 16/17 (94.12) |
| Stent used (SFA) | 10/59 (16.95) |
| Stent used (infrainguinal) | 0/4 (0) |
| Acute success of endovascular therapy | 54/59 (91.52) |
| Restenosis | 9/54 (16.67) |
SFA: Superficial femoral artery